SCHEMBL19863059

SCHEMBL19863059

c1ccc(-c2ccc(-c3cc4c5ccccc5oc4c4c3c3ccccc3n4-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 4/20 0.34
FLT3 P36888 4/20 0.34
KDM4E B2RXH2 3/20 0.33
HPGD P15428 3/20 0.33
MAPT P10636 3/20 0.33
MAPK1 P28482 3/20 0.33
ALDH1A1 P00352 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
GRM5 P41594 1/20 0.33
ACHE P22303 3/20 0.32
MKNK1 Q9BUB5 2/20 0.32
MKNK2 Q9HBH9 2/20 0.32
KDR P35968 2/20 0.32
ACACA Q13085 1/20 0.32
ALOX5 P09917 1/20 0.32
KMT2A Q03164 1/20 0.31
POLB P06746 1/20 0.31
PPARG P37231 1/20 0.31
MCL1 Q07820 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19862891 0.94 KDM4E (0.35) PDGFRBFLT3KDM4EHPGDMAPT
SCHEMBL19863091 0.94 MAPT (0.38) PDGFRBFLT3KDM4EHPGDMAPT
SCHEMBL18594179 0.93 KMT2A (0.34) PDGFRBFLT3KDM4EHPGDMAPT
SCHEMBL19863056 0.92 MAPT (0.33) PDGFRBFLT3KDM4EHPGDMAPT
SCHEMBL19863060 0.90 MAPT (0.36) KDM4EHPGDMAPTMAPK1ALDH1A1
SCHEMBL19863078 0.90 MAPT (0.35) KDM4EHPGDMAPTMAPK1ALDH1A1
SCHEMBL19862888 0.89 KDM4E (0.33) KDM4EALDH1A1L3MBTL1ALOX5KMT2A
SCHEMBL19862887 0.89 KDM4E (0.33) KDM4EALDH1A1L3MBTL1ALOX5KMT2A
SCHEMBL18594352 0.89 MAPT (0.37) KDM4EHPGDMAPTMAPK1ALDH1A1
SCHEMBL18594134 0.88 MAPT (0.36) KDM4EHPGDMAPTMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 PDGFRB 3205/4885FLT3 1172/4885KDM4E 1039/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 PDGFRB 3205/4885FLT3 1172/4885KDM4E 1039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.